Vericel Corporation | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (43)

View All

Latest Posts

About This Stock More About This Stock
Trading SMID Biotech Stocks In A Volatile Market
Article By: Rod Raynovich
Monday, July 1, 2024 10:35 AM EDT
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a broader market where technology rules.
In this article: CRMD, ADPT, GERN, NVAX, CPRX, SUPN, RNA, VCEL, NTRA, CRSP, VCYT, IMTX, ABOS
Read
Research Report: Vericel Corporation
Article By: Elle Investments
Wednesday, April 1, 2020 12:00 PM EDT
Shares sold off hard from the COVID-19 panic. But they have plenty of cash, no debt, and we are confident that strong MACI sales growth will resume once elective surgeries do.
In this article: VCEL
Read
Vericel - Chart Of The Day
Article By: Jim Van Meerten
Tuesday, February 27, 2018 2:25 PM EDT
Since the Trend Spotter signaled a buy on 2/13 the stock gained 9.53%.
In this article: VCEL
Read
Week In Review: China Pharma Signs Cross-Border Deals
Article By: ChinaBio® Today
Saturday, May 13, 2017 1:35 PM EDT
China's Tasly Pharma formed a partnership with Pharnext SA, a French company that combines and re-positions approved drugs to develop innovative therapies (see story).
In this article: MDT, VCEL
Read
The FDA: Small-Cap Catalyst Or Small-Cap Killer?
Article By: Paradigm Press
Friday, December 16, 2016 9:37 AM EDT
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.
In this article: BMY, LLY, MRK, PFE, AMGN, CORT, VYGR, SRPT, VCEL, AKAO, CERC, PRTO, OPHT
Read
All Posts

Latest Tweets for $VCEL

No tweets yet!

PARTNER HEADLINES